|
Preparing the Laboratory for Neoadjuvant Cancer Immunotherapy: Insights from a Pathology Learning Collaborative
American Journal of Clinical Pathology, Volume 162, Issue Supplement_1, October 2024, Page S125 doi.org/10.1093/ajcp/aqae129.277 Assessing the Feasibility of a Cancer Biomarker Testing Navigator in the Laboratory American Journal of Clinical Pathology, Volume 162, Issue Supplement_1, October 2024, Page S122 doi.org/10.1093/ajcp/aqae129.270 Impact of a PD-L1 Learning Collaborative: outcomes from a mixed-methods evaluation American Journal of Clinical Pathology, Volume 162, Issue Supplement_1, October 2024, Pages S143–S144 doi.org/10.1093/ajcp/aqae129.319 Integrating Biomarker Testing into EHR Systems: Implications for the Laboratory Based on Findings from a Multistakeholder Summit American Journal of Clinical Pathology, Volume 162, Issue Supplement_1, October 2024, Page S101 doi.org/10.1093/ajcp/aqae129.225 ASCP has released 3 CME activities to cover recent updates on pan-tumor HER2 testing in advanced solid tumors.
Updates in HER2-directed Therapies in Solid Tumors https://store.ascp.org/productlisting/productdetail?productId=173008379 HER2 Testing in Gynecologic Cancers and Implications for Treatment https://store.ascp.org/productlisting/productdetail?productId=173041833 HER2 Testing in Other Solid Tumors and Implications for Treatment https://store.ascp.org/productlisting/productdetail?productId=173042038
Scroll down to read each Tweet of this CME Tweetorial on pan-tumor HER2 testing!
Click on each Tweet below to open on Twitter: x.com/ASCP_Chicago/status/1840785569023995962 Claim CME here: store.ascp.org/productlisting/productdetail?productId=172789750
Claim CME here: store.ascp.org/productlisting/productdetail?productId=172789750
Here are a series of online CME/CE activities covering cancer biomarker testing and precision oncology in patients with actionable genomic alterations:
clinicaloptions.com/program/oncology/reshaping-care-biomarker-testing-in-solid-tumors/28010
Twitter (X) for CME!
Here is a CME Tweetorial on the topic of pan-tumor HER2 in advanced gynecologic cancers. Read through these threaded tweets: x.com/ASCP_Chicago/status/1826660024975782312 Claim CME credit here: t.co/iJjqlWc47f
The following poster was presented at the 2024 World Conference on Lung Cancer: EP.07D.03 A Quality Improvement Initiative to Address Biomarker Testing and Quality of Care Delivery for Early-Stage NSCLC at 3 Cancer Centers in the US Journal of Thoracic Oncology, October 2024, Volume 19, Issue 10, S548-S549 doi.org/10.1016/j.jtho.2024.09.1016  The following posters were presented at the 2024 ASCP Annual Meeting in Chicago:
Results of a quality improvement program to increase complete lung cancer biomarker testing rates by focusing on system, physician, and other factors associated with adverse health outcomes
Journal of Clinical Oncology 42, 2024 (suppl 16; abstr e23249) doi.org/10.1200/JCO.2024.42.16_suppl.e23249 Evaluating perceived barriers to optimal care in head and neck cancer: A mixed-methods study Journal of Clinical Oncology 42, 2024 (suppl 16; abstr 6079) ascopubs.org/doi/10.1200/JCO.2024.42.16_suppl.6079 Integrating electronic health records (EHRs) to facilitate cancer biomarker testing: Real-world implementation barriers and solutions Journal of Clinical Oncology 42, 2024 (suppl 16; abstr e13649) doi.org/10.1200/JCO.2024.42.16_suppl.e13649
EP12.02-10 Personalizing Care for Patients with Advanced ALK+ NSCLC through a Blended Continuing Education and Quality Improvement Initiative
Journal of Thoracic Oncology, Volume 18, Issue 11, S678 doi.org/10.1016/j.jtho.2023.09.1303 EP07.04-22 Current Biomarker Testing Practices for Early Stage Non-small Cell Lung Cancer (NSCLC) In Community and Academic Centers in the US Journal of Thoracic Oncology, Volume 18, Issue 11, S554 doi.org/10.1016/j.jtho.2023.09.1035 EP07.04 EARLY-STAGE NON-SMALL CELL LUNG CANCER - PROGRESS IN PATHOLOGY| VOLUME 18, ISSUE 11, SUPPLEMENT , S554, NOVEMBER 2023 EP12.02 METASTATIC NON-SMALL CELL LUNG CANCER – TARGETED THERAPY - FUSIONS| VOLUME 18, ISSUE 11, SUPPLEMENT , S678, NOVEMBER 2023 |
